Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at

Genomic Centers for Infectious Diseases (GCID)

The NIAID Genomic Centers for Infectious Diseases (GCID) provide insights into the biology of microbes, their role in pathogenesis, and their interactions with the host, including the microbiome, by supporting a diverse set of genomic capabilities, such as next-generation sequencing and related genomic technologies.

Main Areas of Focus

  • To use and develop or improve innovative applications of genomic technologies, such as RNA sequencing and metagenomics
  • To provide rapid and cost-efficient production of high-quality genome sequences of microorganisms, invertebrate vectors of infectious diseases, and hosts and host microbiomes
  • Multiple strains and isolates of specific microbial species, populations, and communities have been and continue to be sequenced
Content last reviewed on November 17, 2017